Market Overview

Infinity Pharmaceuticals, Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) will be presenting at the 30th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2012 at 2:00 p.m. PST (5:00 p.m. EST) at the Westin St. Francis Hotel in San Francisco, CA.

A live webcast of Infinity's presentation will be accessible on the "investors/media" section of the company's website, www.infi.com, and will be available for 30 days following the event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs focused on the inhibition of the Hedgehog pathway, heat shock protein 90, phosphoinositide-3-kinase and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com.

Infinity Pharmaceuticals, Inc.
Jaren Irene Madden, 617-453-1336
Jaren.Madden@infi.com
http://www.infi.com

 

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional